Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P 500 Equal Weight Health Care ETF

36.52
+0.44001.22%
Volume:87.39K
Turnover:3.18M
Market Cap:843.25M
PE:- -
High:36.62
Open:36.58
Low:36.29
Close:36.08
52wk High:38.19
52wk Low:28.26
Shares:23.09M
Float Shares:23.09M
Volume Ratio:1.49
T/O Rate:0.38%
Dividend:0.23
Dividend Rate:0.63%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

TIPRANKS
·
Sep 08

CSL Seeks ASX Quotation for New Shares from Employee Incentive Plan

TIPRANKS
·
Sep 08

Ceryvyn Therapeutics Plans Issue of 3 Million Long-Dated Options

TIPRANKS
·
Sep 08

China Securities Reports Medical Device Sector Sustains Earnings Improvement While Medical Services Revenue Grows Steadily

Stock News
·
Sep 08

Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids

Stock News
·
Sep 07

Medical Device Inspection Campaign Launched by Ningyang County Market Regulators

Deep News
·
Sep 07

MedTech Firm Joins Hong Kong Market: Evaluating MEDCAPTAIN's (02041) True Investment Potential

Stock News
·
Sep 07

Qurient Plans Investor Roadshow at 2026 KIS BioTech Day in Singapore and Hong Kong

TIPRANKS
·
Sep 07

Brain-Computer Interface Startups Must Walk the Line Between Vast Potential and Near-Term Medical Reality, Says Formatia Founder

Deep News
·
Sep 05

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

TIPRANKS
·
Sep 05

AcroMeta Moves Into Cell Therapy Logistics With Southeast Asia ATCLS Deal

TIPRANKS
·
Sep 05

SD Biotechnologies Faces KOSDAQ Delisting Decision After Improvement Period

TIPRANKS
·
Sep 03

Yinchuan Market Regulators Roll Out Comprehensive Measures to Implement Revised Medical Device Production Quality Standards

Deep News
·
Sep 03

Alterity Therapeutics to Spotlight MSA Program at Cantor Global Healthcare Conference

TIPRANKS
·
Sep 03

Citizens biotechnology analyst holds analyst/industry conference call

TIPRANKS
·
Sep 03

Shenzhen Regulator Launches 2026 Roadshow Selection for Key Medical Device Innovation Projects

Deep News
·
Sep 02

Shinva Medical Secures Class II and III Device Approvals for Advanced Radiotherapy and Thoracoscopic Systems

Stock News
·
Sep 02

Ajinomoto Advances Major Share Buyback, Plans Cancellation of Repurchased Stock

TIPRANKS
·
Sep 02

Aptabio Therapeutics Plans Seoul NDR to Deepen R&D Dialogue with Institutions

TIPRANKS
·
Sep 02

港股动态:今海医疗科技股价攀升逾4%,中期收益激增逾1.3倍,核心业务向高附加值医疗器械领域转型

Stock News
·
Sep 02